A spinoff from the University of North Carolina at Chapel Hill has won a $2 million federal grant to help it commercialize its medical technology.
The company, Morphormics Inc., will use the grant from the National Cancer Institute to market the technology, meant to improve radiation treatment in patients who have prostate cancer.